BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7914453)

  • 21. Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer.
    Socinski MA
    Oncologist; 1999; 4(5):408-16. PubMed ID: 10551557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taxol: a history of pharmaceutical development and current pharmaceutical concerns.
    Adams JD; Flora KP; Goldspiel BR; Wilson JW; Arbuck SG; Finley R
    J Natl Cancer Inst Monogr; 1993; (15):141-7. PubMed ID: 7912520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tour de paclitaxel: biocatalysis for semisynthesis.
    Patel RN
    Annu Rev Microbiol; 1998; 52():361-95. PubMed ID: 9891802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-agent paclitaxel in the treatment of breast cancer: phase I and II development.
    Seidman AD
    Semin Oncol; 1999 Jun; 26(3 Suppl 8):14-20. PubMed ID: 10403469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nursing management of the patient receiving Taxol therapy.
    Noone MH; McCabe MS; Denicoff AM; Lepore JM
    J Natl Cancer Inst Monogr; 1993; (15):149-54. PubMed ID: 7912521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A phase II clinical study of China-made paclitaxel in the treatment of cancer patients].
    Wu H; Guan Z; Lin T
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):148-52. PubMed ID: 10920970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
    von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
    Chang AY; Boros L; Asbury R; Hui L; Rubins J
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taxol commercial supply strategy.
    DeFuria MD; Horovitz Z
    J Natl Cancer Inst Monogr; 1993; (15):195-8. PubMed ID: 7912526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy.
    Johnson KR; Young KK; Fan W
    Clin Cancer Res; 1999 Sep; 5(9):2559-65. PubMed ID: 10499633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total synthesis of taxol.
    Nicolaou KC; Yang Z; Liu JJ; Ueno H; Nantermet PG; Guy RK; Claiborne CF; Renaud J; Couladouros EA; Paulvannan K
    Nature; 1994 Feb; 367(6464):630-4. PubMed ID: 7906395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.
    Luck HJ; Thomssen C; duBois A; Lisboa BW; Untch M; Kuhnle H; Konecny G; Janicke F; Meerpohl HG; Lindner C; Hecker D; Diergarten K
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):33-6. PubMed ID: 8629034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer.
    Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BV
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):13-8. PubMed ID: 8629030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells.
    AbouEl Hassan MA; Braam SR; Kruyt FA
    Cancer Gene Ther; 2006 Dec; 13(12):1105-14. PubMed ID: 16841078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
    Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Taxol plus radiation for head and neck cancer.
    Rosenthal DI; Carbone DP
    J Infus Chemother; 1995; 5(2):46-54. PubMed ID: 8521234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological activity and chemistry of taxoids from the Japanese yew, Taxus cuspidata.
    Shigemori H; Kobayashi J
    J Nat Prod; 2004 Feb; 67(2):245-56. PubMed ID: 14987066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel (taxol).
    Kohler DR; Goldspiel BR
    Pharmacotherapy; 1994; 14(1):3-34. PubMed ID: 7909150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel pharmacology and other tumor types.
    Rowinsky EK
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-1-S19-12. PubMed ID: 9427257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
    Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.